Eritrea vs Sur: Previously treated cases tested for RR-/MDR-TB
Eritrea
100.0%
in 2024
Sur
62.0%
in 2024
Eritrea rank
1st
Sur rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Eritrea
- Sur
How they compare
Eritrea currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Eritrea's figure about 1.6 times Sur's.
The two have swapped places 7 times across 11 shared years of data; in 2013 it was Sur ahead.
Eritrea ranks 1st and Sur ranks 1st of 180 countries.
Across the 2 decades both report, Eritrea averaged higher in 1 and Sur in 1.
Head to head by decade
| Decade | Eritrea | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.4% | 66.0% | 9.6% | Sur |
| 2020s | 100.0% | 78.4% | 21.6% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Eritrea or Sur?
- Eritrea, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Eritrea and Sur?
- 38.0%, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and Sur?
- 11 years are reported by both, from 2013 to 2024.
- How do Eritrea and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Eritrea ranks 1st and Sur ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.